Cytotoxic effector function of CD4-independent, CD8+ T cells is mediated by TNF-α/TNFR

Transplantation

Volumn 94, Issue 11, 2012, Pages 1103-1110

  Zimmerer, Jason M ^a   Horne, Phillip H ^a   Fiessinger, Lori A ^a   Fisher, Mason G ^a   Pham, Thomas A ^a   Saklayen, Samiya L ^a   Bumgardner, Ginny L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

CD4+ T cells; CD8+ T cells; FasL; TNF

Indexed keywords

FAS LIGAND; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; EFFECTOR CELL; GRAFT SURVIVAL; HUMAN; IMMUNOSTIMULATION; IN VIVO STUDY; LIVER GRAFT; LIVER GRAFT REJECTION; LYMPHOCYTOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD95; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HEPATOCYTES; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871537183     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318270f3c0     Document Type: Article

References (69)

1. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 2003; 171: 27.
2. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
3. Halloran PF, Urmson J, Ramassar V, et al. Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or gran-zymes A and B. Am J Transplant 2004; 4: 705.
4. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
5. Han D, Xu X, Baidal D, et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 2281.
6. Sleater M, Diamond AS, Gill RG. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles. Am J Transplant 2007; 7: 1927.
7. Niederkorn JY, Stevens C, Mellon J, et al. Differential roles of CD8+ and CD8-T lymphocytes in corneal allograft rejection in 'high-risk' hosts. Am J Transplant 2006; 6: 705.
8. Meiraz A, Garber OG, Harari S, et al. Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo. Immunology 2009; 128: 69.
9. Martin PJ, Akatsuka Y, Hahne M, et al. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 1998; 92: 2177.
10. Horne PH, Lunsford KE, Walker JP, et al. Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection. Cell Transplant 2008; 17: 829.
11. Lunsford KE, Gao D, Eiring AM, et al. Evidence for tissue directed immune responses: analysis of CD4-dependent and CD8-dependent alloimmunity. Transplantation 2004; 78: 1125.
12. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474.
13. Lindell DM, Moore TA, McDonald RA, et al. Generation of anti-fungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol 2005; 174: 7920.
14. Dikopoulos N, Riedl P, Schirmbeck R, et al. Novel peptide-based vaccines efficiently prime murine WhelpW-independent CD8+ T cell responses in the liver. Hepatology 2004; 40: 300.
15. Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004; 4: 595.
16. Nakanishi Y, Lu B, Gerard C, et al. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009; 462: 510.
17. Horne PH, Koester MA, Jayashankar K, et al. Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells. J Immunol 2007; 179: 80.
18. Lunsford KE, Jayanshankar K, Eiring AM, et al. Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intra-hepatic islet allografts. Am J Transplant 2008; 8: 1113.
19. Lunsford KE, Horne PH, Koester MA, et al. Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells. Am J Transplant 2006; 6: 2268.
20. Zimmerer JM, Pham TA, Sanders VM, et al. CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production. J Immunol 2010; 185: 7285.
21. Horne PH, Lunsford KE, Eiring AM, et al. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloanti-body. Transplantation 2005; 80: 514.
22. Bumgardner GL, Gao D, Li J, et al. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice. Transplantation 2000; 70: 1771.
23. Yamazaki K, Nguyen T, Podack ER. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J Immunol 1999; 163: 5178.
24. Graser RT, DiLorenzo TP, Wang F, et al. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 2000; 164: 3913.
25. Desvignes C, Etchart N, Kehren J, et al. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J Immunol 2000; 164: 2515.
26. He G, Hart J, Kim OS, et al. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67: 131.
27. Newell KA, He G, Guo Z, et al. Blockade of the CD28/B7 costimu-latory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999; 163: 2358.
28. Shelton MW, Walp LA, Basler JT, et al. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells. Transplantation 1992; 54: 278.
29. Trambley J, Bingaman AW, Lin A, et al. Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715.
30. Han WR, Zhan Y, Murray-Segal LJ, et al. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Transplantation 2000; 70: 168.
31. Jones ND, Van-Maurik A, Hara M, et al. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol 2000; 165: 1111.
32. + cells and CD40-CD40 ligand interactions. J Immunol 2001; 166: 3248.
33. Bumgardner GL, Gao D, Li J, et al. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 2000; 70: 1771.
34. + cells that independently initiate rejection of alloge-neic hepatocytes in mice. Hepatology 2000; 32: 1018.
35. Bumgardner GL, Li J, Prologo JD, et al. Patterns of immune responses evoked by allogeneic hepatocytes. I. Evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation 1999; 68: 555.
36. Csencsits KL, Bishop DK. Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction. Am J Transplant 2003; 3: 107.
37. Le Moine A, Goldman M. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am J Transplant 2003; 3: 101.
38. Boleslawski E, Conti F, Sanquer S, et al. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 2004; 77: 1815.
39. Wang Y, Gao D, Lunsford KE, et al. Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am J Transplant 2003; 3: 1251.
40. Bumgardner GL, Gao D, Li J, et al. MHC-identical heart and hepa-tocyte allografts evoke opposite immune responses within the same host. Transplantation 2002; 74: 855.
41. Guo Z, Meng L, Kim O, et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costi-mulatory pathway. Transplantation 2001; 71: 1351.
42. + T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512.
43. Williams MA, Trambley J, Ha J, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-Independent rejection of skin allografts. J Immunol 2000; 165: 6849.
44. Meng L, Guo Z, Kim O, et al. Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection. Transplant Proc 2001; 33: 418.
45. Szot GL, Zhou P, Rulifson I, et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1: 38.
46. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323.
47. Heusel JW, Wesselschmidt RL, Shresta S, et al. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977.
48. Kojima H, Toda M, Sitkovsky MV. Comparison of Fas-versus perforin-mediated pathways of cytotoxicity in TCR-and Thy-1-activated murine T cells. Int Immunol 2000; 12: 365.
49. Adam C, King S, Allgeier T, et al. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005; 106: 338.
50. Kean LS, Hamby K, Koehn B, et al. NK cells mediate costimula-tion blockade-resistant rejection of allogeneic stem cells during non-myeloablative transplantation. Am J Transplant 2006; 6: 292.
51. Horne PH, Zimmerer JM, Fisher MG, et al. Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells. J Immunol 2008; 181: 1224.
52. Langrehr JM, Gube K, Hammer MH, et al. Short-term anti-CD4 plus anti-TNF-alpha receptor treatment in allogeneic small bowel transplantation results in long-term survival. Transplantation 2007; 84: 639.
53. Pascher A, Klupp J, Langrehr JM, et al. Anti-TNF-alpha therapy for acute rejection in intestinal transplantation. Transplant Proc 2005; 37: 1635.
54. Gerlach UA, Koch M, Muller HP, et al. Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation. Am J Transplant 2011; 11: 1041.
55. Ahmed KR, Guo TB, Gaal KK. Islet rejection in perforin-deficient mice: the role of perforin and Fas. Transplantation 1997; 63: 951.
56. Diamond AS, Gill RG. Resistance to induction of long-term allograft survival in IFNg-deficient mice maps to a hyperaggressive CD8 T cell subset. Transplantation 2000; 69: S298.
57. Zimmerman Z, Shatry A, Deyev V, et al. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Biol Blood Marrow Transplant 2005; 11: 576.
58. Diamond AS, Gill RG. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts. J Immunol 2000; 165: 247.
59. Hsieh MH, Korngold R. Differential use of FasL-and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood 2000; 96: 1047.
60. Abougergi MS, Gidner SJ, Spady DK, et al. Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of mu-rine liver adenoviral infection. Hepatology 2005; 41: 97.
61. Roth E, Pircher H. IFN-gamma promotes Fas ligand-and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol 2004; 172: 1588.
62. Kennedy NJ, Russell JQ, Michail N, et al. Liver damage by infiltrating CD8+ T cells is Fas dependent. J Immunol 2001; 167: 6654.
63. Kafrouni MI, Brown GR, Thiele DL. The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection. J Leukoc Biol 2003; 74: 564.
64. Borson ND, Strausbauch MA, Kennedy RB, et al. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts. Transplantation 1999; 67: 672.
65. Beuneu H, Garcia Z, Bousso P. Cutting edge: cognate CD4 help promotes recruitment of antigen-specific CD8 T cells around dendritic cells. J Immunol 2006; 177: 1406.
66. Agarwal P, Raghavan A, Nandiwada SL, et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 2009; 183: 1695.
67. Gerner MY, Casey KA, Mescher MF. Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. J Immunol 2008; 181: 155.
68. Curtsinger JM, Gerner MY, Lins DC, et al. Signal 3 availability limits the CD8 T cell response to a solid tumor. J Immunol 2007; 178: 6752.
69. Bumgardner GL, Heininger M, Li J, et al. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 1998; 65: 53.